Table 2 Measurement overview
| Aim | Outcome measures | Time point | ||
|---|---|---|---|---|
| Instrument | Baseline (t0) | Two weeks after randomization (t1) | Three months after baseline measurement (t2) | |
| Efficacy | ||||
| Primary outcome measure | Patient Activation | X | X | X |
| Patient Activation Measure (PAM) | ||||
| Secondary outcome measures | Self-efficacy | X | X | X |
| General Self-Efficacy Scale (GSE) | ||||
| Health-related quality of life | X | X | X | |
| EORTC QLQ-C15 PAL | ||||
| Cost-utility | ||||
| Quality-adjusted life years | X | X | ||
| EuroQol 5 Dimensions (EQ-5D) | ||||
| Medical costs | X | X | ||
| iMTA Medical Consumption Questionnaire (iMCQ) | ||||
| Productivity costs | X | X | ||
| iMTA Productivity Cost Questionnaire (iPCQ) | ||||